Lexicon Pharmaceuticals Inc (LXRX)

Precedente Chiudi:

$1.92

Aprire:

$1.97

Volume 24 ore:

861.13K

Capitalizzazione di mercato:

$703.10M

Reddito:

$1.21M

Utile/perdita netta:

$-177.12M

Rapporto P/E:

-2.8393

EPS:

-0.68

Flusso di cassa netto:

$-162.37M

1 W Prestazione:

+9.60%

1M Prestazione:

+3.74%

6M Prestazione:

+70.18%

1 anno Prestazione:

-34.90%

Intervallo 1D:

$1.91

$2.04

Portata 52W:

$0.92

$3.73

Lexicon Pharmaceuticals Inc Stock (LXRX) Company Profile

Nome

Lexicon Pharmaceuticals Inc

Settore

Healthcare (1213)

Industria

Biotechnology (696)

Telefono

281-863-3000

Indirizzo

8800 Technology Forest Place, The Woodlands

Dipendente

174

Cinguettio

@LexPharma

Prossima data di guadagno

2024-05-14

Ultimi documenti SEC

LXRX's Discussions on Twitter

Lexicon Pharmaceuticals Inc Stock (LXRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-03-07	Iniziato	Jefferies	Hold
2022-08-12	Iniziato	Piper Sandler	Overweight
2021-01-29	Aggiornamento	JP Morgan	Underweight → Neutral
2021-01-29	Downgrade	Wedbush	Outperform → Neutral
2020-12-08	Aggiornamento	Citigroup	Neutral → Buy
2020-11-18	Aggiornamento	Gabelli & Co	Hold → Buy
2019-12-11	Downgrade	Gabelli & Co	Buy → Hold
2019-11-08	Downgrade	Citigroup	Buy → Neutral
2019-09-11	Aggiornamento	Gabelli & Co	Hold → Buy
2019-07-29	Downgrade	Stifel	Buy → Hold
2019-03-25	Aggiornamento	Gabelli & Co	Sell → Hold
2018-07-31	Reiterato	Stifel	Buy
2018-02-23	Downgrade	Needham	Buy → Hold
2018-02-14	Downgrade	JP Morgan	Neutral → Underweight
2017-03-01	Reiterato	H.C. Wainwright	Buy
2017-03-01	Reiterato	Wedbush	Outperform
2016-10-07	Iniziato	H.C. Wainwright	Buy
2016-08-05	Reiterato	Wedbush	Outperform
2016-08-02	Iniziato	Citigroup	Buy
2016-03-02	Reiterato	Wedbush	Outperform
2015-11-09	Reiterato	Wedbush	Outperform
2015-09-28	Aggiornamento	Gabelli & Co	Sell → Hold
2015-09-18	Downgrade	Gabelli & Co	Hold → Sell
2015-08-10	Downgrade	JP Morgan	Overweight → Neutral

Mostra tutto

Lexicon Pharmaceuticals Inc Borsa (LXRX) Ultime notizie

Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024

GlobeNewswire Inc.

Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Lexicon Pharmaceuticals to Host 2024 Investor Day

GlobeNewswire Inc.

All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy

Zacks Investment Research

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday

Benzinga

Lexicon Pharmaceuticals Inc Azioni (LXRX) Dati Finanziari

Lexicon Pharmaceuticals Inc (LXRX) Reddito 2024

Lexicon Pharmaceuticals Inc (LXRX) Reddito netto 2024

Lexicon Pharmaceuticals Inc (LXRX) Flusso di cassa 2024

Lexicon Pharmaceuticals Inc (LXRX) Utile per azione 2024

Lexicon Pharmaceuticals Inc Azioni (LXRX) insider trading